EX-99.1 2 b59259wcexv99w1.htm EX-99.1 - PRESS RELEASE DATED 2/17/2006 exv99w1
 

Exhibit 99.1
Contact: Gene Cassis, Vice President of Investor Relations, 508-482-2349
WATERS CORPORATION AND AGILENT TECHNOLOGIES DEUTSCHLAND
GmbH RESOLVE OUTSTANDING HPLC LITIGATION
Milford, Massachusetts, February 17, 2006 – Waters Corporation (NYSE/WAT) reported today it had entered into a settlement agreement with Agilent Technologies Deutschland GmbH resolving certain outstanding HPLC related litigation between them.
The settlement provides for the resolution of a finding of patent infringement by a court in the United Kingdom with respect to a portion of the pump technology used in Waters’ Alliance HPLC instruments. In 2002, Waters discontinued the use of the patented technology and the settlement has no effect on the Company’s ability to sell its Alliance HPLC instruments in the United Kingdom.
In connection with the settlement, Waters and its United Kingdom affiliate have been released from any claims of past infringement under the patent and Waters has agreed to make a one time payment to Agilent of 3.5 million British Pounds Sterling.
As a result of the settlement, Waters has revised its fourth quarter 2005 and full year 2005 results as previously reported in a press release on January 24, 2006, to include a pre-tax $3.1 million provision for damages and estimated remaining costs related to this matter. This has reduced GAAP earnings per diluted share for the fourth quarter of 2005 to $0.69 per diluted share from $0.71 per diluted share and to $1.74 per diluted share from $1.76 per diluted share for the full year 2005. Updated condensed financial statements are attached.
Similar patent infringement actions to the case noted above are currently pending in France and Germany. Waters believes, however, that any potential damages resulting from these ongoing disputes are unlikely to be materially different from amounts previously recorded.
Waters Corporation holds worldwide leading positions in three complementary analytical technologies – liquid chromatography, mass spectrometry and thermal analysis. These markets account for $4.5 - $5.0 billion of the overall $20 + billion analytical instrument market.

 


 

Certain statements contained herein are forward looking. Many factors could cause actual results to differ from these statements, in particular, uncertainties of litigation.

 


 

Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
                                 
    (Unaudited)   (Unaudited)
    Three Months Ended   Year Ended
    December 31,   December 31,   December 31,   December 31,
    2005   2004   2005   2004
 
                               
Net sales
    332,270       324,154       1,158,236       1,104,536  
Cost of sales
    133,980       130,144       478,355       454,807  
 
                               
Gross profit
    198,290       194,010       679,881       649,729  
 
                               
Selling and administrative expenses
    81,593       80,916       321,694       300,150  
Research and development expenses
    16,691       16,475       66,905       65,241  
Purchased intangibles amortization
    1,216       1,236       5,005       4,814  
Litigation provisions and settlement (A)
    3,122             3,122       (9,277 )
Impairment of long-lived asset (B)
          3,997             3,997  
Restructuring and other unusual charges, net
                      (54 )
 
                               
Operating income
    95,668       91,386       283,155       284,858  
 
                               
Other expense, net (C)
    (3,103 )     (1,014 )     (3,103 )     (1,014 )
Interest (expense) income, net
    (3,421 )     156       (5,489 )     1,827  
Income from operations before income taxes
    89,144       90,528       274,563       285,671  
 
                               
Provision for income taxes (D)
    13,546       19,011       72,588       61,618  
 
                               
Net income
    75,598       71,517       201,975       224,053  
 
                               
Net income per basic common share
  $ 0.70     $ 0.59     $ 1.77     $ 1.87  
 
                               
Weighted average number of basic common shares
    108,364       120,266       114,023       119,640  
 
                               
Net income per diluted common share
  $ 0.69     $ 0.58     $ 1.74     $ 1.82  
 
                               
Weighted average number of diluted common shares and equivalents
    109,962       122,679       115,945       123,069  
 
(A)   The results for the three months and year ended December 31, 2005 include provisions of $3.1 million for ongoing patent litigation with Hewlett-Packard Company. The results for the year ended December 31, 2004 include provisions of $7.8 million for the same ongoing patent litigation with Hewlett-Packard Company as well as settlement income of $17.1 million related to patent litigation with Perkin-Elmer Corporation.
 
(B)   The results for the three months and year ended December 31, 2004 include charges of $4.0 million recorded for a write-down of a technology licensed asset.
 
(C)   The results for the three months and year ended December 31, 2005 include charges of $4.8 million recorded for a write-off of an equity investment and gain of $1.7 million related to the sale of an equity investment. The results for the three months and year ended December 31, 2004 include charges of $1.0 million recorded for full write-down of an investment in an unaffiliated company.
 
(D)   The results for the year ended December 31, 2005 include a tax provision of approximately $24.0 million related to a qualified dividends distribution under the American Jobs Creation Act of 2004.

 


 

Waters Corporation and Subsidiaries
Consolidated Statements of Operations
(In thousands, except per share data)
                                 
    (Unaudited)   (Unaudited)
    Three Months Ended   Year Ended
    December 31,   December 31,   December 31,   December 31,
    2005   2004   2005   2004
 
                               
Reconciliation of income per diluted share, in accordance with generally accepted accounting principles, with adjusted results:
                               
 
                               
Income per diluted share
  $ 0.69     $ 0.58     $ 1.74     $ 1.82  
 
                               
 
                               
Adjustment for litigation provisions and settlement, net of tax
    2,569             2,569       (5,688 )
Income per diluted share effect
    0.02             0.02       (0.05 )
 
                               
 
                               
Adjustment for restructuring and other unusual charges, net of tax
                        (57 )
Income per diluted share effect
                      (0.00 )
 
                               
 
                               
Adjustment for tax provision for qualified dividends distribution
                24,000        
Income per diluted share effect
                0.21        
 
                               
 
                               
Impairment of long-lived asset, net of tax
          3,158             3,158  
Income per diluted share effect
          0.03             0.03  
 
                               
 
                               
Other expense, write down and sale of certain investments, net of tax
    2,554       801       2,554       801  
Income per diluted share effect
    0.02       0.01       0.02       0.01  
 
                               
 
                               
Adjusted income per diluted share:
  $ 0.73     $ 0.62     $ 1.99     $ 1.81  
 
                               
 
    The adjusted income per diluted share presented above is used by the management of the Company to measure operating performance with prior periods and is not in accordance with generally accepted accounting principles (GAAP). The above reconciliation identifies items management has excluded as non-operational transactions. Management feels these transactions are not indicative of understanding the ongoing operations of the business or its future outlook.

 


 

Waters Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands and unaudited)
                 
    December 31, 2005   December 31, 2004
 
               
Cash and cash equivalents
    493,588       539,077  
Accounts receivable
    256,809       271,731  
Inventories
    131,554       139,900  
Other current assets
    31,550       23,176  
Total current assets
    913,501       973,884  
 
               
Property, plant and equipment, net
    141,030       135,908  
Other assets
    387,874       350,634  
Total assets
    1,442,405       1,460,426  
 
               
Notes payable and debt
    326,286       206,663  
Accounts payable and accrued expenses
    278,544       286,327  
Total current liabilities
    604,830       492,990  
 
               
Long-term debt
    500,000       250,000  
Other long-term liabilities
    41,408       38,750  
Total liabilities
    1,146,238       781,740  
 
               
Total equity
    296,167       678,686  
Total liabilities and equity
    1,442,405       1,460,426